APA (7th ed.) Citation

K, M., JFH, P., B, A., KS, B., I, H., C, R., . . . L, G. (2025). Dlk1 is a novel adrenocortical stem/progenitor cell marker that predicts malignancy in adrenocortical carcinoma. Cancer communications (London, England), 45(6), 663. https://doi.org/10.1002/cac2.70012

Chicago Style (17th ed.) Citation

K, Mariniello, et al. "Dlk1 Is a Novel Adrenocortical Stem/progenitor Cell Marker That Predicts Malignancy in Adrenocortical Carcinoma." Cancer Communications (London, England) 45, no. 6 (2025): 663. https://doi.org/10.1002/cac2.70012.

MLA (9th ed.) Citation

K, Mariniello, et al. "Dlk1 Is a Novel Adrenocortical Stem/progenitor Cell Marker That Predicts Malignancy in Adrenocortical Carcinoma." Cancer Communications (London, England), vol. 45, no. 6, 2025, p. 663, https://doi.org/10.1002/cac2.70012.